Thames Water’s £16bn rescue deal is close — lenders may take 30% losses

Thames Water’s £16bn rescue deal is close — lenders may take 30% losses

Creditors are nearing a £16 billion rescue deal for Thames Water, with senior lenders facing losses of up to 30% on Class A debt, according to reports. The plan would give creditors at least a 10% equity stake in the recapitalised utility. A creditor group holding £13 billion of debt aims to reach terms with Ofwat by mid-February. Thames Water serves 16 million customers and has faced over £100 million in fines for sewage spills.
3 February 2026
Xero share price jumps on AI push and fresh US payments numbers — here’s what investors watch next

Xero share price jumps on AI push and fresh US payments numbers — here’s what investors watch next

Xero shares rose 2.6% to A$96.10 after an investor briefing outlined AI and U.S. payments plans. The company expects Melio to reach adjusted-EBITDA breakeven by H2 FY28. BillPay payments revenue jumped 74% to NZ$158 million in FY25, while U.S. gross margin slipped to 38%. Xero will update its guidance framework with full-year results on May 14.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 03.02.2026

Insider selling by U.S. executives hit a five-year high as the S&P 500 topped 7,000, raising correction fears amid warnings from the IMF and Northern Trust. Infosys shares fell over 6%, dragging Sensex and Nifty lower after weakness in U.S. tech stocks. Nintendo shares dropped 10% on chip shortage concerns despite strong Switch sales. Gulf markets rose ahead of earnings, supported by non-oil growth and higher oil output.
3 February 2026
PayPal stock (PYPL) slips near lows ahead of earnings — what traders watch Tuesday

PayPal stock (PYPL) slips near lows ahead of earnings — what traders watch Tuesday

PayPal shares fell 0.7% to $52.33 Monday ahead of its quarterly earnings report, due before Tuesday’s market open. Analysts expect earnings of $1.29 per share on $8.79 billion revenue, with focus on branded checkout growth and margin forecasts for 2026. Investors are watching for signs of slowing market share and management’s plans for product investment. The company’s earnings webcast is set for 8:00 a.m. ET Tuesday.
IBM stock price jumps 2.6% as CEO share filing and new bond paperwork hit the tape

IBM stock price jumps 2.6% as CEO share filing and new bond paperwork hit the tape

IBM shares rose $8.01, or 2.6%, to close at $314.73 Monday after the company projected over 5% revenue growth for 2026 and announced a $1.68 quarterly dividend. CEO Arvind Krishna received 83,028 shares via performance units and sold 41,133 for tax withholding, according to an SEC filing. IBM also disclosed new debt offerings totaling €3.5 billion and $3.25 billion. The Dow gained 1.05% as U.S. stocks closed higher.
3 February 2026
1 84 85 86 87 88 1,636

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Go toTop